Dolby Laboratories (NYSE:DLB) SVP Sells $500,018.75 in Stock

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,273 shares of the business’s stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $68.75, for a total value of $500,018.75. Following the sale, the senior vice president owned 108,065 shares of the company’s stock, valued at approximately $7,429,468.75. This represents a 6.31% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Dolby Laboratories Stock Performance

Shares of Dolby Laboratories stock traded down $0.96 during trading hours on Monday, reaching $66.58. The company’s stock had a trading volume of 541,392 shares, compared to its average volume of 469,418. The company has a market capitalization of $6.36 billion, a P/E ratio of 25.31 and a beta of 0.89. The stock’s fifty day simple moving average is $67.15 and its two-hundred day simple moving average is $71.39. Dolby Laboratories has a one year low of $64.02 and a one year high of $89.66.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.70 by $0.29. The business had revenue of $307.02 million during the quarter, compared to the consensus estimate of $305.76 million. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.Dolby Laboratories’s revenue was up .7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.61 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, research analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd were issued a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 2.2%. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date was Tuesday, December 2nd. Dolby Laboratories’s dividend payout ratio is 54.75%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Robert W. Baird initiated coverage on shares of Dolby Laboratories in a report on Friday, September 5th. They issued a “neutral” rating and a $74.00 price target on the stock. Baird R W upgraded Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Barrington Research dropped their price objective on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a report on Wednesday, November 19th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday, December 8th. Finally, Rosenblatt Securities cut their price objective on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a report on Wednesday, November 19th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Dolby Laboratories presently has an average rating of “Moderate Buy” and a consensus target price of $92.00.

Institutional Trading of Dolby Laboratories

A number of hedge funds have recently bought and sold shares of the stock. Allworth Financial LP increased its holdings in shares of Dolby Laboratories by 99.6% in the 3rd quarter. Allworth Financial LP now owns 1,006 shares of the electronics maker’s stock valued at $73,000 after acquiring an additional 502 shares during the period. Swiss Life Asset Management Ltd bought a new stake in Dolby Laboratories during the third quarter valued at about $210,000. Advisory Services Network LLC bought a new stake in Dolby Laboratories during the third quarter valued at about $102,000. XTX Topco Ltd purchased a new position in Dolby Laboratories in the third quarter valued at about $741,000. Finally, Verition Fund Management LLC raised its holdings in Dolby Laboratories by 172.4% in the third quarter. Verition Fund Management LLC now owns 35,409 shares of the electronics maker’s stock worth $2,563,000 after purchasing an additional 22,409 shares in the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.